Efficacy of Adjuvant 9-Weeks Trastuzumab in Node-Negative T1A/B Her2-Positive Breast Cancer

Simple item page
dc.contributor.authorSendur, M. A.
dc.contributor.authorAksoy, S.
dc.contributor.authorUncu, D.
dc.contributor.authorDemir, H.
dc.contributor.authorYuksel, S.
dc.contributor.authorEkinci, A. S.
dc.contributor.authorKaplan, A.
dc.contributor.authorUstaalioglu, B. B.
dc.contributor.authorTufan, G.
dc.contributor.authorInanc, M.
dc.contributor.authorOzdemir, N.
dc.contributor.authorArtac, M.
dc.contributor.authorTastekin, D.
dc.contributor.authorKacan, T.
dc.contributor.authorOguz, A.
dc.contributor.authorArpaci, E.
dc.contributor.authorYazilitas, D.
dc.contributor.authorGumus, M.
dc.contributor.authorZengin, N.
dc.contributor.authorAltundag, M. K.
dc.contributor.orcIDhttps://orcid.org/0000-0001-6512-6534en_US
dc.contributor.researcherIDW-8004-2019en_US
dc.date.accessioned2023-12-05T13:20:25Z
dc.date.available2023-12-05T13:20:25Z
dc.date.issued2014
dc.identifier.issn0923-7534en_US
dc.identifier.urihttp://hdl.handle.net/11727/10988
dc.identifier.volume25en_US
dc.identifier.wos000346901000167en_US
dc.language.isoengen_US
dc.relation.isversionof10.1093/annonc/mdu327.44en_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEfficacy of Adjuvant 9-Weeks Trastuzumab in Node-Negative T1A/B Her2-Positive Breast Canceren_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine